Track: Diabetes and Liver Disease

Diabetes and Liver Disease

Session Overview: This session will provide invaluable information to clinicians, researchers, and healthcare professionals to enhance the care and treatment of patients living with both diabetes and liver disease

Diabetes and Liver Function
Impact of diabetes on liver metabolism
Insulin resistance and its effects on the liver
Mechanisms linking type 2 diabetes and liver disease

Non-Alcoholic Fatty Liver Disease (NAFLD) and Diabetes
Pathophysiology of NAFLD in diabetic patients
Risk factors and early detection strategies
Role of obesity and metabolic syndrome in the development of NAFLD

Non-Alcoholic Steatohepatitis (NASH) and Diabetes
Progression of NAFLD to NASH in diabetic patients
Biomarkers for diagnosing NASH
Current therapeutic approaches for NASH management

Cirrhosis and Diabetes
Diabetes as a risk factor for liver cirrhosis
Managing diabetes in cirrhotic patients
Liver transplantation considerations for diabetic individuals

Hepatocellular Carcinoma (HCC) in Diabetic Patients
The link between diabetes and the development of liver cancer
Screening and diagnostic tools for early detection of HCC
Treatment options and management strategies for HCC in diabetic patients

Clinical Management of Diabetes and Liver Disease
Multidisciplinary approaches to managing patients with both conditions
Medications for managing diabetes in the context of liver disease
Lifestyle modifications and their role in improving liver and metabolic health

Emerging Research and Future Directions
Advances in pharmacotherapy for diabetes-related liver diseases
The role of liver transplantation in diabetic patients
Cutting-edge research on gene therapies and new biomarkers for liver disease management

If you're the one interested in presenting your research by submitting your abstract and registering for the session